Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

J&J’s Care4Today brand joins Twitter

Firm's Janssen Healthcare Innovation unit also makes its debut on the social network

- PMLiVE

More woes for Daiichi as Ranbaxy units stop API shipments

Manufacturing problems continue to gather pace

- PMLiVE

AbbVie uses art gallery in inflammation campaign

Aims to improve understanding of immune-mediated inflammatory diseases

- PMLiVE

Ariad appoints new board member

Alexander Denner is chief investment officer of Sarissa Capital Management

- PMLiVE

Three hires for The EarthWorks

Agency marks first anniversary with new account manager, digital designer and app developer

- PMLiVE

Value-based assessment

NICE is set to modify the way it operates, but the changes shouldn’t come as a surprise

- PMLiVE

FDA expands efforts to test quality of generics

Monitoring programme to ensure drug copies are equivalent to branded medicines

National Institute for Health and Care Excellence NICE logo

Janssen launches diabetes drug Invokana in UK

Launch coincides with draft NICE recommendation for the SGLT2 inhibitor

- PMLiVE

Teva’s Symbicort generic backed for EU approval

AstraZeneca braces for competition to COPD drug

- PMLiVE

Samsung sets up digital health innovation lab

Forms mobile health partnership to develop new sensors, algorithms and digital health technologies

Par hires Antonio Pera as commercial head

Follows acquisition of Pera’s former company JHP Pharmaceuticals

- PMLiVE

Janssen Invokana combination recommended for European approval

Drug adds metformin to the firm's new SGLT2 inhibitor

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links